ADIM
HOLX

Alpha DNA Investment Management’s Hologic HOLX Stock Holding History

Alpha DNA Investment Management’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-18,899
Closed -$1.53M – 185
2023
Q1 		$1.53M Buy
+18,899
New +$1.52M 0.45% 32
2022
Q2 		– Sell
-19,111
Closed -$1.47M – 142
2022
Q1 		$1.47M Buy
+19,111
New +$1.37M 1.03% 11
2021
Q2 		– Sell
-76
Closed -$5K – 336
2021
Q1 		$5K Buy
76
+53
+230% +$4.02K 0.01% 363
2020
Q4 		$1K Buy
+23
New +$1.62K ﹤0.01% 526

Other funds holding HOLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Alpha DNA Investment Management's HOLX Position: Q2 2023 in Review

Alpha DNA Investment Management sold out of Hologic (HOLX) in Q2 2023, closing a stake of 18,899 shares — an estimated $1.53M sold.

Alpha DNA Investment Management first reported a position in HOLX in Q4 2020 and held it in 4 quarters. The position peaked at $1.53M in Q1 2023. 713 funds tracked by Wall St. Rank hold HOLX as of Q2 2023.

  • Alpha DNA Investment Management reported no remaining Hologic position as of Q2 2023 after selling out during the quarter.
  • Alpha DNA Investment Management sold 18,899 Hologic shares in Q2 2023, an estimated $1.53M.
  • Alpha DNA Investment Management first reported a position in Hologic in Q4 2020 and held it in 4 quarters.
  • Alpha DNA Investment Management's Hologic position peaked at $1.53M in Q1 2023.
  • 713 funds tracked by Wall St. Rank held Hologic as of Q2 2023.

Based on Alpha DNA Investment Management's 13F filing for Q2 2023, filed 31 Jul 2023.